within Pharmacolibrary.Drugs.ATC.S;

model S01AA29
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0016666666666666668,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00026000000000000003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01AA29</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Dibekacin is a semisynthetic aminoglycoside antibiotic, structurally related to kanamycin and amikacin. It has been used for the treatment of severe infections caused by Gram-negative bacteria, including Pseudomonas aeruginosa and other resistant organisms. Dibekacin is generally administered via injection. It is not approved or available in many countries today due to the availability of newer, less nephrotoxic aminoglycosides.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are generally estimated from intravenous administration in adult patients with normal renal function. Specific published PK studies in humans are very limited, so these parameters are estimated based on the general aminoglycoside class and a few old studies referenced in reviews.</p><h4>References</h4><ol><li><p>Autret, E, et al., &amp; Laugier, J (1984). Pharmacodynamics and pharmacokinetics of dibekacin in the neonate--comparison between the intramuscular and intravenous routes. <i>Developmental pharmacology and therapeutics</i> 7 Suppl 1 121–124. DOI:<a href=&quot;https://doi.org/10.1159/000457240&quot;>10.1159/000457240</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6518951/&quot;>https://pubmed.ncbi.nlm.nih.gov/6518951</a></p></li><li><p>Komiya, I, et al., &amp; Fujita, M (1981). Pharmacokinetics of dibekacin in rabbits and dogs. <i>Journal of pharmacobio-dynamics</i> 4(5) 362–373. DOI:<a href=&quot;https://doi.org/10.1248/bpb1978.4.362&quot;>10.1248/bpb1978.4.362</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7288554/&quot;>https://pubmed.ncbi.nlm.nih.gov/7288554</a></p></li><li><p>Komiya, I, et al., &amp; Fujita, M (1981). Acute toxicity and pharmacokinetics of dibekacin mice. <i>Journal of pharmacobio-dynamics</i> 4(5) 356–361. DOI:<a href=&quot;https://doi.org/10.1248/bpb1978.4.356&quot;>10.1248/bpb1978.4.356</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7288553/&quot;>https://pubmed.ncbi.nlm.nih.gov/7288553</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01AA29;
